Pfizer, Inc. (
) will begin trading ex-dividend on January 30, 2013. A cash
dividend payment of $0.24 per share is scheduled to be paid on
March 05, 2013. Shareholders who purchased PFE stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
represents an 9.09% increase over the prior quarter.
The previous trading day's last sale of PFE was $27,
representing a -1.1% decrease from the 52 week high of $27.30 and a
30.12% increase over the 52 week low of $20.75.
PFE is a part of the Consumer Durables sector, which includes
companies such as Johnson & Johnson (
) and Novartis AG (
). PFE's current earnings per share, an indicator of a company's
profitability, is $1.29. Zacks Investment Research reports PFE's
forecasted earnings growth in 2012 as -6.32%, compared to an
industry average of -3.6%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to PFE through an Exchange
Traded Fund [ETF]?
The following ETF(s) have PFE as a top-10 holding:
- Merrill Lynch Pharmaceutical HOLDRS (
- iShares Dow Jones U.S. Pharmaceutical Index Fund (
- Select Sector SPDR Fund - Health Care (
- iShares Dow Jones U.S. Health Care Index Fund (
- Vanguard Health Care ETF (
The top-performing ETF of this group is XLV with an increase of
10.3% over the last 100 days. PPH has the highest percent weighting
of PFE at 9.83%.